Pharma News

VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved QSYMIA (phentermine and topiramate extended-release capsules) CIV for use in the treatment of obesity in adoles...

The FDA has expanded its approval of Incyte’s Opzelura (ruxolitinib) topical cream to include adult and pediatric patients 12 years and older with nonsegmental vitiligo, a chronic autoimmune dis...

The FDA has approved Azurity Pharmaceuticals’ Zonisade (zonisamide oral suspension) as an adjunctive therapy for the treatment of partial seizures in epilepsy patients aged 16 years and older. ...

Currently, there is no cure for amyotrophic lateral sclerosis (ALS). 

Polpharma Biologics has become the first company to file for approval in the EU of a biosimilar version of Biogen’s blockbuster multiple sclerosis therapy Tysabri. ...

Scientists at Cedars-Sinai Medical Center in Los Angeles are trying to find new ways to produce huge batches of a type of stem cell that can generate nearly any other type of cell in the body -- an...

The European Medicines Agency has accepted Byondis’ application for its investigational drug trastuzumab duocarmazine for treatment of patients with human epidermal growth factor receptor 2 (HER2...

Bayer has sold off the rights to Nebido (testosterone undecanoate), its injectable treatment for testosterone deficiency, to Grünenthal for approximately $503 million. ...

Most vaccines, from measles to Covid-19, require a series of multiple shots before the recipient is considered fully vaccinated.

Ancora Heart has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the Accucinch ventricular restoration system. ...

The Food and Drug Administration (FDA) recently granted Alpheus Medical orphan drug and fast track designations for its investigational CV-01 delivery of sonodynamic therapy as a potential treatme...

Many Alzheimer’s clinical trials researchers express optimism that they are entering a new era.